Copyright
©The Author(s) 2016.
World J Pharmacol. Mar 9, 2016; 5(1): 1-14
Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.1
Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.1
Trade name | Generic name | Study | Main conclusion | Ref. |
Lucentis | Ranibizumab | RISE/RIDE | Ranibizumab improved vision and macular edema in DME patients | [82] |
Eylea | Aflibercept | VISTA/VIVID | Intravitreal injection of aflibercept was shown to be superior compared to laser therapy in treatment of DME | [91] |
Ozurdex | Dexamethasone implant | MEAD | Dexamethasone implant were well tolerated and improved BCVA in DME patients | [168] |
Iluvien | Fluocinolone acetonide | FAME | Both low and high dose of Fluocinolone acetonide exhibited improved BCVA in treatment of DME | [169] |
- Citation: Trinh HM, Joseph M, Cholkar K, Pal D, Mitra AK. Novel strategies for the treatment of diabetic macular edema. World J Pharmacol 2016; 5(1): 1-14
- URL: https://www.wjgnet.com/2220-3192/full/v5/i1/1.htm
- DOI: https://dx.doi.org/10.5497/wjp.v5.i1.1